miR-133a is decreased in pathological left ventricular hypertrophy [23], and miR-133a limits the production of CTGF and COL1A1 by directly targeting their 3′-UTR regions [20, 23, 37]. Here, CCN2 is linked to left ventricular hypertrophy.